192
Philipp S, Yang X-M, Cui L, Davis AM, Downey JM, Cohen MV (2006) Postconditioning pro-
tects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc Res
70:308–314
Pieroni M, Corti A, Tota B, Curnis F, Angelone T, Colombo B et al (2007) Myocardial production
of chromogranin A in human heart: a new regulatory peptide of cardiac function. Eur Heart
J 28:1117–1127
Piper HM, Meuter K, Schäfer C (2003) Cellular mechanisms of ischemia-reperfusion injury. Ann
Thorac Surg 75:S644–S648
Radomski MW, Palmer RM, Moncada S (1987) The role of nitric oxide and cGMP in platelet
adhesion to vascular endothelium. Biochem Biophys Res Commun 148:1482–1489
Ramella R, Boero O, Alloatti G, Angelone T, Levi R, Gallo MP (2010) Vasostatin 1 activates eNOS
in endothelial cells through a proteoglycan-dependent mechanism. J Cell Biochem 110:70–79
Reffelmann T, Kloner RA (2002) The “no-reflow” phenomenon: basic science and clinical cor-
relates. Heart 87:162–168
Ronson RS, Nakamura M, Vinten-Johansen J (1999) The cardiovascular effects and implications
of peroxynitrite. Cardiovasc Res 44:47–59
Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of Akt/
PKB by the rictor-mTOR complex. Science 307:1098–1101
Schreck R, Albermann K, Baeuerle PA (1992) Nuclear factor kappa B: an oxidative stress- responsive
transcription factor of eukaryotic cells (a review). Free Radic Res Commun 17:221–237
Schulz R, Kelm M, Heusch G (2004) Nitric oxide in myocardial ischemia/reperfusion injury.
Cardiovasc Res 61:402–413
Siegmund B, Schlüter KD, Piper HM (1993) Calcium and the oxygen paradox. Cardiovasc Res
27:1778–1783
Simkhovich BZ, Przyklenk K, Kloner RA (2013) Role of protein kinase C in ischemic "condition-
ing": from first evidence to current perspectives. J Cardiovasc Pharmacol Ther 18:525–532
Skyschally A, van Caster P, Iliodromitis EK, Schulz R, Kremastinos DT, Heusch G (2009) Ischemic
postconditioning: experimental models and protocol algorithms. Basic Res Cardiol 104:469–483
Szelényi Z, Fazakas Á, Szénási G, Kiss M, Tegze N, Fekete BC et al (2015) Inflammation and oxi-
dative stress caused by nitric oxide synthase uncoupling might lead to left ventricular diastolic
and systolic dysfunction in patients with hypertension. J Geriatr Cardiol 12:1–10
Tatemoto K, Efendić S, Mutt V, Makk G, Feistner GJ, Barchas JD (1986) Pancreastatin, a novel
pancreatic peptide that inhibits insulin secretion. Nature 324:476–478
Tissier R, Cohen MV, Downey JM (2007) Protecting the acutely ischemic myocardium beyond
reperfusion therapies: are we any closer to realizing the dream of infarct size elimination? Arch
Mal Coeur Vaiss 100:794–802
Tritto I, Ambrosio G (2001) Role of oxidants in the signaling pathway of preconditioning. Antioxid
Redox Signal 3:3–10
Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM (2004) Postconditioning: a form of "modi-
fied reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt
pathway. Circ Res 95:230–232
Tullio F, Angotti C, Perrelli MG, Penna C, Pagliaro P (2013) Redox balance and cardioprotection.
Basic Res Cardiol 108:392
Vinten-Johansen J, Granfeldt A, Mykytenko J, Undyala VV, Dong Y, Przyklenk K (2011) The mul-
tidimensional physiological responses to postconditioning. Antioxid Redox Signal 14:791–810
Wagner C, Ebner B, Tillack D, Strasser RH, Weinbrenner C (2013) Cardioprotection by ischemic
postconditioning is abrogated in hypertrophied myocardium of spontaneously hypertensive
rats. J Cardiovasc Pharmacol 61:35–41
Wang X, Xu S, Liang Y, Zhu D, Mi L, Wang G et al (2011) Dramatic changes in catestatin are
associated with hemodynamics in acute myocardial infarction. Biomarkers 16:372–377
C. Penna and P. Pagliaro